Krane Funds Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Sell
23,901
-3,486
-13% -$23.2K 0.01% 176
2026
Q1
$146K Buy
27,387
+11,167
+69% +$62.7K 0.01% 168
2025
Q4
$114K Buy
16,220
+3,789
+30% +$29.7K ﹤0.01% 156
2025
Q3
$106K Buy
12,431
+1,469
+13% +$11.5K ﹤0.01% 137
2025
Q2
$95.5K Sell
10,962
-1,675
-13% -$12.1K ﹤0.01% 138
2025
Q1
$101K Sell
12,637
-325
-3% -$3.29K ﹤0.01% 119
2024
Q4
$118K Buy
+12,962
New +$125K ﹤0.01% 112

Other funds holding TDOC

Krane Funds Advisors's TDOC Position: Q2 2026 in Review

Krane Funds Advisors reduced its Teladoc Health (TDOC) stake by 13% in Q2 2026, selling an estimated $23.2K and leaving 23,901 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #176.

Krane Funds Advisors first reported a position in TDOC in Q4 2024 and has held it in 7 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Krane Funds Advisors held 23,901 shares of Teladoc Health worth $203K as of Q2 2026.
  • Krane Funds Advisors sold 3,486 Teladoc Health shares in Q2 2026, an estimated $23.2K.
  • Teladoc Health made up 0.01% of Krane Funds Advisors's portfolio in Q2 2026, its #176 holding.
  • Krane Funds Advisors first reported a position in Teladoc Health in Q4 2024 and has held it in 7 quarters since.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Krane Funds Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.